You are hereBiblio / Addressing conflicts of interest in nanotechnology oversight: lessons learned from drug and pesticide safety testing

Addressing conflicts of interest in nanotechnology oversight: lessons learned from drug and pesticide safety testing


By csep - Posted on 05 November 2012

TitleAddressing conflicts of interest in nanotechnology oversight: lessons learned from drug and pesticide safety testing
Publication TypeJournal Article
Year of Publication2012
AuthorsElliott, Kevin C., and Volz David C.
JournalJournal of Nanoparticle Research
Volume14
Issue1
Date Published1/2012
ISSN Number1572-896X
KeywordsNanotechnology Policy and Development
Abstract

Financial conflicts of interest raise significant challenges for those working to develop an effective, transparent, and trustworthy oversight system for assessing and managing the potential human health and ecological hazards of nanotechnology. Based on past experiences with standardized test guidelines developed by the international Organization for Economic Cooperation and Development (OECD) and implemented by national regulatory agencies such as the U.S. Environmental Protection Agency (EPA) and Food and Drug Administration (FDA), the authors argue that this approach still runs the risk of allowing conflicts of interest to influence toxicity tests, and it has the potential to commit regulatory agencies to outdated procedures. The authors suggest an alternative approach.

DOI10.1007/s11051-011-0664-9
Short TitleJ Nanopart Res